ResMed, Inc. (RMD) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $201.10 --0%
EPS Growth %: +13.3%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
PKE, LNN, More
EPS Growth %: +13.3%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $314.8 million versus the consensus estimate of $326.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
- Nike (NKE) Tops Q4 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
